טוען...
Molecular Therapeutics in Development for Epidermolysis Bullosa: Update 2020
Epidermolysis bullosa (EB) is a group of rare genetic disorders for which significant progress has been achieved in the development of molecular therapies in the last few decades. Such therapies require knowledge of mutant genes and specific mutations, some of them being allele specific. A relativel...
שמור ב:
| הוצא לאור ב: | Mol Diagn Ther |
|---|---|
| Main Authors: | , , |
| פורמט: | Artigo |
| שפה: | Inglês |
| יצא לאור: |
Springer International Publishing
2020
|
| נושאים: | |
| גישה מקוונת: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7264085/ https://ncbi.nlm.nih.gov/pubmed/32328988 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s40291-020-00466-7 |
| תגים: |
הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!
|